Business & Consumer Services » Consumer Services | Hong Kong Life Sciences & Technologies Group Ltd.

Hong Kong Life Sciences & Technologies Group Ltd. | Income Statement

Fiscal year is April-March. All values HKD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
679,891.00
320,079.00
123,372.00
153,572.00
140,208.00
99,362
Cost of Goods Sold (COGS) incl. D&A
665,268.00
293,143.00
93,528.00
118,518.00
111,596.00
76,447
Gross Income
14,623.00
26,936.00
29,844.00
35,054.00
28,612.00
22,915
SG&A Expense
74,244.00
65,374.00
44,872.00
72,694.00
96,550.00
41,518
EBIT
59,621.00
-
15,028.00
37,620.00
67,938.00
18,603
Unusual Expense
87,580.00
35,061.00
30,507.00
32,803.00
15,092.00
-
Non Operating Income/Expense
8,553.00
7,402.00
4,052.00
2,458.00
-
3,050
Pretax Income
132,825.00
77,175.00
41,111.00
67,963.00
83,027.00
23,272
Income Tax
12.00
1,709.00
656.00
-
-
-
Consolidated Net Income
132,837.00
78,884.00
41,767.00
67,963.00
83,027.00
23,272
Net Income
123,618.00
71,457.00
36,498.00
64,708.00
82,200.00
23,240
Net Income After Extraordinaries
71,497.00
61,780.00
30,829.00
64,708.00
82,200.00
23,240
Net Income Available to Common
175,739.00
81,134.00
38,072.00
64,708.00
82,200.00
23,240
EPS (Basic)
0.05
0.02
0.01
0.01
0.01
-
Basic Shares Outstanding
3,679,765.70
3,950,332.80
4,138,119.70
4,961,114.80
5,688,396.80
5,688,396.80
EPS (Diluted)
0.04
0.02
0.01
0.01
0.01
-
Diluted Shares Outstanding
4,108,099.00
3,950,332.80
4,138,119.70
4,961,114.80
5,688,396.80
5,688,396.80
EBITDA
52,121.00
30,326.00
6,672.00
30,577.00
63,346.00
17,419
Other Operating Expense
-
-
-
20.00
-
-
Non-Operating Interest Income
5,823.00
3,726.00
372.00
2.00
3.00
18
Minority Interest Expense
9,219.00
7,427.00
5,269.00
3,255.00
827.00
32

About Hong Kong Life Sciences & Technologies Group

View Profile
Address
Unit 2704, 27/F
Hong Kong
Hong Kong
Employees -
Website http://www.hklifesciences.com
Updated 07/08/2019
Hong Kong Life Sciences & Technologies Group Ltd. is an investment holding company, which engages in the provision of anti-aging and stem cell technology; trading, and financial services. It operates through the following business segments: Anti-aging and Stem Cell Technology; Trading; Money Lending; and Securities Investment. The Anti-aging and Stem Cell Technology business segment manufactures and sells biomedical and life science products; provides health check and beauty services; and offers lease of anti-aging platform.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.